High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel

• Yanwei Luo,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Xinye Wang,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Heran Wang,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Yang Xu,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Qiuyuan Wen,

  Affiliation The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, 410011, P. R. China

  ⨯
• Songqing Fan,

  Affiliation The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan, 410011, P. R. China

  ⨯
• Ran Zhao,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Shihe Jiang,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Jing Yang,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Yukun Liu,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Xiayu Li,

  Affiliation The Third Xiang-Ya Hospital, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Wei Xiong,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Jian Ma,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Shuping Peng,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Zhaoyang Zeng,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Xiaoling Li,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Joshua B. Phillips,

  Affiliation Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, 36604, United States of America

  ⨯
• Guiyuan Li,

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• Ming Tan ,

  * E-mail: mtan@health.southalabama.edu (MT); zhouming2001@163.com (MZ)

  Affiliation Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, 36604, United States of America

  ⨯
•  [ ... ],
• Ming Zhou

  * E-mail: mtan@health.southalabama.edu (MT); zhouming2001@163.com (MZ)

  Affiliation The Affiliated Tumor Hospital of Xiangya Medical School, Cancer Research Institute, Central South University, Changsha, Hunan, 410013, P. R. China

  ⨯
• [ view all ]
• [ view less ]